High Tide has reported its financial results for the fourth quarter and the full fiscal year 2025, highlighting record revenue and adjusted EBITDA. The company maintained positive free cash flow throughout the year and achieved strong same-store sales growth. Additionally, High Tide continued to expand its footprint in the German medical cannabis market.
The company’s performance reflects ongoing demand and operational efficiencies, contributing to its solid financial position. These results demonstrate High Tide’s ability to grow within competitive markets while managing cash flow effectively.
**Why this matters**
High Tide’s record financial results indicate robust growth in the medical cannabis sector, particularly in Germany, a key market for the company. Maintaining positive free cash flow supports sustainable operations and potential future investments. This performance may influence investor confidence and strategic planning in the cannabis industry.